Dassault Systèmes: invests in bioserenity

(CercleFinance.com) - Dassault Systèmes announces its participation, as lead investor, in a 65 million euro B Series financing in the start-up company BioSerenity, alongside three historical investors - BPI, Idinvest and LBO.


Founded in 2014 and based in Paris, BioSerenity specialises in the development of comprehensive and powerful textile medical devices that include sensors and online telehealth services for the diagnosis and monitoring of chronic diseases.

The funds raised will be used to continue the development of its solutions beyond their initial objective (cardiovascular, neurological and sleep disorders), while developing the group's activities internationally and designing new telemedicine solutions.


Copyright (c) 2019 CercleFinance.com. All rights reserved.